ES258463A1 - Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis - Google Patents
Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitisInfo
- Publication number
- ES258463A1 ES258463A1 ES0258463A ES258463A ES258463A1 ES 258463 A1 ES258463 A1 ES 258463A1 ES 0258463 A ES0258463 A ES 0258463A ES 258463 A ES258463 A ES 258463A ES 258463 A1 ES258463 A1 ES 258463A1
- Authority
- ES
- Spain
- Prior art keywords
- type
- avirulent
- virus
- poliomyelitis
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un procedimiento de preparar una vacuna trivalente viva contra la poliomielitis adecuada para administración oral cuando está en forma de dosis unitaria, caracterizada por mezclar virus atenuado de poliomielitis Tipo I avirulento para seres humanos, virus atenuado de poliomielitis Tipo III avirulento para seres humanos, virus atenuado de poliomielitis Tipo II que tiene adaptación en embrión de pollo y avirulento para seres humanos, y que no inhibe la infección por virus avirulentos Tipo I y Tipo III, y formar unidades de dosificación a partir de la mezcla resultante conteniendo cada una por lo menos log 6 de cada tipo de virus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US821720A US2966443A (en) | 1959-06-22 | 1959-06-22 | Trivalent poliomyelitis live virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ES258463A1 true ES258463A1 (es) | 1960-11-16 |
Family
ID=25234127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES0258463A Expired ES258463A1 (es) | 1959-06-22 | 1960-05-30 | Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis |
Country Status (5)
Country | Link |
---|---|
US (1) | US2966443A (es) |
BE (1) | BE591268A (es) |
ES (1) | ES258463A1 (es) |
FR (1) | FR668M (es) |
LU (1) | LU38816A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3147185A (en) * | 1959-09-10 | 1964-09-01 | Merck & Co Inc | Process for purifying viral substances and composition |
GB896439A (en) * | 1959-12-28 | 1962-05-16 | Glaxo Lab Ltd | Cellulose derivatives useful as anion-exchange materials and their application |
US3244590A (en) * | 1960-12-23 | 1966-04-05 | Rutgers Res And Educational Fo | Polyenic compounds and procedures related thereto |
DE1157734B (de) * | 1961-08-16 | 1963-11-21 | Behringwerke Ag | Verfahren zur Herstellung von haltbaren, oral zu verabreichenden Poliomyelitisvirus-Praeparaten |
US3143473A (en) * | 1961-08-16 | 1964-08-04 | Behringwerke Ag | Stable, solid, oral live antipoliomyelitis vaccine compositions and process for preparing them |
US3128229A (en) * | 1961-10-05 | 1964-04-07 | Baylor Medical Foundation | Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein |
GB1015251A (en) * | 1963-03-12 | 1965-12-31 | Glaxo Lab Ltd | Aqueous pharmaceutical compositions in capsule form |
GB1171125A (en) * | 1966-06-08 | 1969-11-19 | Glaxo Lab Ltd | Improvements in or relating to Injectable Preparations |
MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
-
1959
- 1959-06-22 US US821720A patent/US2966443A/en not_active Expired - Lifetime
-
1960
- 1960-05-27 BE BE591268A patent/BE591268A/fr unknown
- 1960-05-30 ES ES0258463A patent/ES258463A1/es not_active Expired
- 1960-06-14 LU LU38816D patent/LU38816A1/xx unknown
- 1960-09-20 FR FR830604A patent/FR668M/fr active Active
Also Published As
Publication number | Publication date |
---|---|
BE591268A (fr) | 1960-11-28 |
FR668M (es) | 1961-07-10 |
US2966443A (en) | 1960-12-27 |
LU38816A1 (es) | 1960-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES258463A1 (es) | Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis | |
ES227680A2 (es) | UN PROCEDIMIENTO DE PRODUCCIoN DE UNA VACUNA DE VIRUS DE POLIOMIELITIS | |
ES394860A1 (es) | Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas. | |
ES294897A1 (es) | Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias | |
ES306989A1 (es) | Procedimiento para la produccion de una composicion de vacuna veterinaria. | |
ES287586A1 (es) | Un procedimiento para la preparación de una composición terapéutica | |
ES306377A1 (es) | Procedimiento para la preparacion de una composicion penetrante por las membranas. | |
GR21931B (el) | Μεθοδος δια την παρασκευην τρισθενους ζωντος εμβολιου πολιομυελιτιδος. | |
ES321833A1 (es) | Procedimiento para la obtencion de una vacuna contra el moquillo | |
ES311990A1 (es) | Procedimiento para la preparacion de vacunas contra la gripe | |
ES371256A1 (es) | Un procedimiento para la preparacion de una vacuna multiva-lente. | |
ES434384A1 (es) | Un procedimiento para preparar una vacuna de virus vivos dela gripe. | |
ES273008A1 (es) | Procedimiento para la obtencion de preparacion de virus de poliomielitis duraderos y administrables por via bucal | |
ES266270A1 (es) | Procedimiento para preparar vacunas poliomieliticas | |
ES281617A1 (es) | Un procedimiento para la fabricación de una composición terapéutica | |
FI40401C (fi) | Menetelmä kestävien, suun kautta nautittavien poliomyelitisvirus-preparaattien valmistamiseksi | |
ES241605A1 (es) | MEJORAS INTRODUCIDAS EN LA PREPARACIoN DE COMPUESTOS ANESTÉSICOS | |
USD146429S (en) | Design for a gameboard | |
CA636550A (en) | Trivalent poliomyelitis live virus vaccine | |
CA607992A (en) | Stable poliomyelitis live virus vaccine | |
ES348634A1 (es) | Mejoras introducidas en un procedimiento para preparar com-posiciones insecticidas. | |
ES301232A1 (es) | Procedimiento para la obtencion de una vacuna contra la glosopeda | |
ES289869A1 (es) | Metodo para esterilizar composiciones acuosas | |
ES246350A1 (es) | Mejoras introducidas en la preparacion de composiciones para el tratamiento esterno de animales | |
ES71929U (es) | Extractor de humos perfeccionado |